{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:05:45Z","timestamp":1784250345991,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471896"],"award-info":[{"award-number":["82471896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02140-8","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:34:58Z","timestamp":1779510898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Luteinizing hormone change trajectories in gonadotropin-releasing hormone antagonist protocols are associated with assisted reproductive outcomes: results from a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Xun","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"4","key":"2140_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmv016","volume":"21","author":"MC Inhorn","year":"2015","unstructured":"Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015;21(4):411\u201326. https:\/\/doi.org\/10.1093\/humupd\/dmv016.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2140_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","volume":"326","author":"SA Carson","year":"2021","unstructured":"Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65\u201376. https:\/\/doi.org\/10.1001\/jama.2021.4788.","journal-title":"JAMA"},{"issue":"4","key":"2140_CR3","doi-asserted-by":"publisher","first-page":"CD1750","DOI":"10.1002\/14651858.CD001750.pub4","volume":"4","author":"HG Al-Inany","year":"2016","unstructured":"Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4(4):CD1750. https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2140_CR4","doi-asserted-by":"publisher","first-page":"CD6919","DOI":"10.1002\/14651858.CD006919.pub4","volume":"2015","author":"CS Siristatidis","year":"2015","unstructured":"Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database Syst Rev. 2015;2015(11):CD6919. https:\/\/doi.org\/10.1002\/14651858.CD006919.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2140_CR5","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","volume":"12","author":"S Kadoura","year":"2022","unstructured":"Kadoura S, Alhalabi M, Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep. 2022;12(1):4456. https:\/\/doi.org\/10.1038\/s41598-022-08400-z.","journal-title":"Sci Rep"},{"key":"2140_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/CMRH.S17788","volume":"8","author":"S Kol","year":"2014","unstructured":"Kol S. Individualized treatment from theory to practice: the private case of adding LH during GnRH antagonist-based stimulation protocol. Clin Med Insights Reprod Health. 2014;8:59\u201364. https:\/\/doi.org\/10.4137\/CMRH.S17788.","journal-title":"Clin Med Insights Reprod Health"},{"key":"2140_CR7","doi-asserted-by":"publisher","first-page":"675670","DOI":"10.3389\/fendo.2021.675670","volume":"12","author":"R Orvieto","year":"2021","unstructured":"Orvieto R, Venetis CA, Fatemi HM, D\u2019Hooghe T, Fischer R, Koloda Y, et al. Optimising follicular development, pituitary suppression, triggering and luteal phase support during assisted reproductive technology: a delphi consensus. Front Endocrinol (Lausanne). 2021;12:675670. https:\/\/doi.org\/10.3389\/fendo.2021.675670.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2140_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s43032-019-00137-x","volume":"27","author":"A Arroyo","year":"2020","unstructured":"Arroyo A, Kim B, Yeh J. Luteinizing hormone action in human oocyte maturation and quality: signaling pathways, regulation, and clinical impact. Reprod Sci. 2020;27(6):1223\u201352. https:\/\/doi.org\/10.1007\/s43032-019-00137-x.","journal-title":"Reprod Sci"},{"issue":"4","key":"2140_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/biolre\/iox112","volume":"97","author":"R Prochazka","year":"2017","unstructured":"Prochazka R, Blaha M, Nemcova L. Significance of epidermal growth factor receptor signaling for acquisition of meiotic and developmental competence in mammalian oocytes. Biol Reprod. 2017;97(4):537\u201349. https:\/\/doi.org\/10.1093\/biolre\/iox112.","journal-title":"Biol Reprod"},{"issue":"5","key":"2140_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/03007995.2017.1417827","volume":"34","author":"JS Younis","year":"2018","unstructured":"Younis JS, Laufer N. Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence? Curr Med Res Opin. 2018;34(5):881\u20136. https:\/\/doi.org\/10.1080\/03007995.2017.1417827.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2140_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmx029","volume":"24","author":"D Richani","year":"2018","unstructured":"Richani D, Gilchrist RB. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Hum Reprod Update. 2018;24(1):1\u201314. https:\/\/doi.org\/10.1093\/humupd\/dmx029.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2140_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/s0015-0282(02)03157-6","volume":"77","author":"Z Shoham","year":"2002","unstructured":"Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril. 2002;77(6):1170\u20137. https:\/\/doi.org\/10.1016\/s0015-0282(02)03157-6.","journal-title":"Fertil Steril"},{"issue":"1","key":"2140_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003.","journal-title":"Fertil Steril"},{"issue":"6","key":"2140_CR14","doi-asserted-by":"publisher","first-page":"67005","DOI":"10.1289\/EHP11309","volume":"131","author":"Y Hao","year":"2023","unstructured":"Hao Y, Wang Y, Yan L, Xu X, Chen D, Zhao Y, et al. Synthetic phenolic antioxidants and their metabolites in follicular fluid and association with diminished ovarian reserve: a case-control study. Environ Health Perspect. 2023;131(6):67005. https:\/\/doi.org\/10.1289\/EHP11309.","journal-title":"Environ Health Perspect"},{"key":"2140_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae145","author":"B Xu","year":"2024","unstructured":"Xu B, Geerts D, Yuan J, Wang M, Li Z, Lai Q, et al. A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial. Hum Reprod. 2024. https:\/\/doi.org\/10.1093\/humrep\/deae145.","journal-title":"Hum Reprod"},{"key":"2140_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2018.00327","volume":"9","author":"D Cimadomo","year":"2018","unstructured":"Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne). 2018;9:327. https:\/\/doi.org\/10.3389\/fendo.2018.00327.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2140_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.fertnstert.2015.10.026","volume":"105","author":"JO Doyle","year":"2016","unstructured":"Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105(2):459\u201366. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.10.026.","journal-title":"Fertil Steril"},{"issue":"4","key":"2140_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/humupd\/dmz011","volume":"25","author":"N Sermondade","year":"2019","unstructured":"Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439\u201351. https:\/\/doi.org\/10.1093\/humupd\/dmz011.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2140_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rbmo.2022.11.008","volume":"46","author":"IM Magaton","year":"2023","unstructured":"Magaton IM, Helmer A, Eisenhut M, Roumet M, Stute P, von Wolff M. Oocyte maturity, oocyte fertilization and cleavage-stage embryo morphology are better in natural compared with high-dose gonadotrophin stimulated IVF cycles. Reprod Biomed Online. 2023;46(4):705\u201312. https:\/\/doi.org\/10.1016\/j.rbmo.2022.11.008.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2140_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humrep\/des389","volume":"28","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod. 2013;28(2):442\u201352. https:\/\/doi.org\/10.1093\/humrep\/des389.","journal-title":"Hum Reprod"},{"issue":"1","key":"2140_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40001-024-01768-w","volume":"29","author":"X Shen","year":"2024","unstructured":"Shen X, Guo Y, Liu Y, Song W, Li G, Jin H. Effects of total gonadotropin dose on embryo quality and clinical outcomes with AMH stratification in IVF cycles: a retrospective analysis of 12,588 patients. Eur J Med Res. 2024;29(1):167. https:\/\/doi.org\/10.1186\/s40001-024-01768-w.","journal-title":"Eur J Med Res"},{"issue":"12","key":"2140_CR22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/humrep\/dex321","volume":"32","author":"TC van Tilborg","year":"2017","unstructured":"van Tilborg TC, Oudshoorn SC, Eijkemans M, Mochtar MH, van Golde R, Hoek A, et al. Individualized FSH dosing based on ovarian reserve testing in women starting IVF\/ICSI: a multicentre trial and cost-effectiveness analysis. Hum Reprod. 2017;32(12):2485\u201395. https:\/\/doi.org\/10.1093\/humrep\/dex321.","journal-title":"Hum Reprod"},{"key":"2140_CR23","doi-asserted-by":"publisher","first-page":"155252","DOI":"10.1016\/j.scitotenv.2022.155252","volume":"833","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zhang J, Cai G, Xia Q, Xu S, Hu C, et al. Inverse association between ambient particulate matter and semen quality in Central China: evidence from a prospective cohort study of 15,112 participants. Sci Total Environ. 2022;833:155252. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.155252.","journal-title":"Sci Total Environ"},{"issue":"3","key":"2140_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/0974-1208.92287","volume":"4","author":"M Momeni","year":"2011","unstructured":"Momeni M, Rahbar MH, Kovanci E. A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles. J Hum Reprod Sci. 2011;4(3):130\u20137. https:\/\/doi.org\/10.4103\/0974-1208.92287.","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"2140_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.rbmo.2019.09.005","volume":"40","author":"G Gao","year":"2020","unstructured":"Gao G, Cui X, Li S, Ding P, Zhang S, Zhang Y. Endometrial thickness and IVF cycle outcomes: a meta-analysis. Reprod Biomed Online. 2020;40(1):124\u201333. https:\/\/doi.org\/10.1016\/j.rbmo.2019.09.005.","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"2140_CR26","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/oxfordjournals.humrep.a135842","volume":"10","author":"TJ Roseboom","year":"1995","unstructured":"Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R. The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod. 1995;10(11):3035\u201341. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a135842.","journal-title":"Hum Reprod"},{"issue":"1","key":"2140_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-clinpsy-081122-012416","volume":"20","author":"DS Nagin","year":"2024","unstructured":"Nagin DS, Jones BL, Elmer J. Recent advances in group-based trajectory modeling for clinical research. Annu Rev Clin Psychol. 2024;20(1):285\u2013305. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081122-012416.","journal-title":"Annu Rev Clin Psychol"},{"issue":"2\u20133","key":"2140_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab. 2014;65(2\u20133):205\u201310. https:\/\/doi.org\/10.1159\/000360229.","journal-title":"Ann Nutr Metab"},{"issue":"2","key":"2140_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10705511.2014.882690","volume":"21","author":"SY Kim","year":"2014","unstructured":"Kim SY. Determining the number of latent classes in single- and multi-phase growth mixture models. Struct Equ Model. 2014;21(2):263\u201379. https:\/\/doi.org\/10.1080\/10705511.2014.882690.","journal-title":"Struct Equ Model"},{"issue":"1","key":"2140_CR30","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1186\/s12889-023-17236-9","volume":"23","author":"J Zhou","year":"2023","unstructured":"Zhou J, Teng Y, Zhang S, Yang M, Yan S, Tao F, et al. Birth outcomes and early growth patterns associated with age at adiposity rebound: the Ma\u2019anshan birth cohort (MABC) study. BMC Public Health. 2023;23(1):2405. https:\/\/doi.org\/10.1186\/s12889-023-17236-9.","journal-title":"BMC Public Health"},{"key":"2140_CR31","doi-asserted-by":"publisher","unstructured":"Nab L, Groenwold RHH, van Smeden M, Keogh RH. Quantitative bias analysis for a misclassified confounder: a comparison between marginal structural models and conditional models for point treatments. Epidemiology (Cambridge, Mass.). 2020;31(6):796\u2013805. https:\/\/doi.org\/10.1097\/EDE.0000000000001239.","DOI":"10.1097\/EDE.0000000000001239"},{"key":"2140_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fendo.2019.00639","volume":"10","author":"A Benmachiche","year":"2019","unstructured":"Benmachiche A, Benbouhedja S, Zoghmar A, Humaidan P. Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF\/ICSI treatment and fresh embryo transfer. Front Endocrinol (Lausanne). 2019;10:639. https:\/\/doi.org\/10.3389\/fendo.2019.00639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2140_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18502\/ijrm.v17i3.4520","volume":"17","author":"RB Hosein","year":"2019","unstructured":"Hosein RB, Kabodmehri R, Shariat M, Shahrokh TE, Abdollahi A, Bagheri M, et al. Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: a cross-sectional study. Int J Reprod Biomed. 2019;17(3):209\u201316. https:\/\/doi.org\/10.18502\/ijrm.v17i3.4520.","journal-title":"Int J Reprod Biomed"},{"issue":"2","key":"2140_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humrep\/deh601","volume":"20","author":"JA Huirne","year":"2005","unstructured":"Huirne JA, van Loenen AC, Schats R, Mcdonnell J, Hompes PG, Schoemaker J, et al. Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF\/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod. 2005;20(2):359\u201367. https:\/\/doi.org\/10.1093\/humrep\/deh601.","journal-title":"Hum Reprod"},{"key":"2140_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7827-5-32","volume":"5","author":"A Kassab","year":"2007","unstructured":"Kassab A, Sabatini L, Lieberman G, Tozer A, Zosmer A, Davis C, et al. Does measuring early basal serum follicular luteinising [correction of lutinising] hormone assist in predicting in vitro fertilization (IVF)\/intracytoplasmic sperm injection (ICSI) outcome? Reprod Biol Endocrinol. 2007;5:32. https:\/\/doi.org\/10.1186\/1477-7827-5-32.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"2140_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4274\/jtgga.galenos.2024.2024-2-9","volume":"25","author":"N Kugelman","year":"2024","unstructured":"Kugelman N, Digby A, Rotshenker-Olshinka K, Bellemare V, Pooni A, Son WY, et al. Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2024;25(4):192\u20139. https:\/\/doi.org\/10.4274\/jtgga.galenos.2024.2024-2-9.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"8","key":"2140_CR37","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.fertnstert.2010.12.046","volume":"95","author":"NE Kummer","year":"2011","unstructured":"Kummer NE, Weitzman VN, Benadiva CA, Schmidt DW, Engmann LL, Nulsen JC. In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle. Fertil Steril. 2011;95(8):2592\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.12.046.","journal-title":"Fertil Steril"},{"key":"2140_CR38","doi-asserted-by":"publisher","first-page":"1232361","DOI":"10.3389\/fendo.2023.1232361","volume":"14","author":"C Pang","year":"2023","unstructured":"Pang C, Wang K, Wang R, Guo D, Wen Z. LH level on the antagonist administration day as a predictor of the reproductive outcomes in women with normal ovarian function. Front Endocrinol (Lausanne). 2023;14:1232361. https:\/\/doi.org\/10.3389\/fendo.2023.1232361.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2140_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3892\/br.2017.984","volume":"7","author":"AC Wang","year":"2017","unstructured":"Wang AC, Wang Y, Wu FX, Zhu DY. Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF\/ICSI - in fresh cycles. Biomed Rep. 2017;7(5):482\u20136. https:\/\/doi.org\/10.3892\/br.2017.984.","journal-title":"Biomed Rep"},{"issue":"6","key":"2140_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/09513590.2019.1683730","volume":"36","author":"D Zhang","year":"2020","unstructured":"Zhang D, Zhang D, Sun Z, Deng C, Yu Q, Zhen J. The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol. Gynecol Endocrinol. 2020;36(6):550\u20133. https:\/\/doi.org\/10.1080\/09513590.2019.1683730.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"2140_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0015-0282(16)38580-6","volume":"22","author":"AV Schally","year":"1971","unstructured":"Schally AV, Kastin AJ, Arimura A. Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril. 1971;22(11):703\u201321.","journal-title":"Fertil Steril"},{"issue":"9","key":"2140_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF03343777","volume":"23","author":"P Beck-Peccoz","year":"2000","unstructured":"Beck-Peccoz P, Romoli R, Persani L. Mutations of LH and FSH receptors. J Endocrinol Invest. 2000;23(9):566\u201372. https:\/\/doi.org\/10.1007\/BF03343777.","journal-title":"J Endocrinol Invest"},{"key":"2140_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1477-7827-12-95","volume":"12","author":"D Ezcurra","year":"2014","unstructured":"Ezcurra D, Humaidan P. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology. Reprod Biol Endocrinol. 2014;12:95. https:\/\/doi.org\/10.1186\/1477-7827-12-95.","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"2140_CR44","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/humrep\/dez132","volume":"34","author":"B Popovic-Todorovic","year":"2019","unstructured":"Popovic-Todorovic B, Santos-Ribeiro S, Drakopoulos P, De Vos M, Racca A, Mackens S, et al. Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation. Hum Reprod. 2019;34(10):2027\u201335. https:\/\/doi.org\/10.1093\/humrep\/dez132.","journal-title":"Hum Reprod"},{"issue":"1","key":"2140_CR45","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1038\/s41598-018-32128-4","volume":"8","author":"L Sun","year":"2018","unstructured":"Sun L, Ye J, Wang Y, Chen Q, Cai R, Fu Y, et al. Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles. Sci Rep. 2018;8(1):13835. https:\/\/doi.org\/10.1038\/s41598-018-32128-4.","journal-title":"Sci Rep"},{"issue":"1","key":"2140_CR46","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","volume":"14","author":"G Pratama","year":"2024","unstructured":"Pratama G, Wiweko B, Asmarinah, Widyahening IS, Andraini T, Bayuaji H, et al. Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis. Sci Rep. 2024;14(1):8229. https:\/\/doi.org\/10.1038\/s41598-024-58064-0.","journal-title":"Sci Rep"},{"issue":"10","key":"2140_CR47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrendo.2014.102","volume":"10","author":"CN Jayasena","year":"2014","unstructured":"Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10(10):624\u201336. https:\/\/doi.org\/10.1038\/nrendo.2014.102.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2140_CR48","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.19540\/j.cnki.cjcmm.20240115.503","volume":"49","author":"K Ma","year":"2024","unstructured":"Ma K, Li JN, Gong LJ, Zhang H. [Bushen Culuan Formula in treatment of infertility caused by polycystic ovary syndrome]. Zhongguo Zhong Yao Za Zhi. 2024;49(8):2006\u201315. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20240115.503.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"2140_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/humrep\/dex334","volume":"33","author":"A Magnusson","year":"2018","unstructured":"Magnusson A, Kallen K, Thurin-Kjellberg A, Bergh C. The number of oocytes retrieved during IVF: a balance between efficacy and safety. Hum Reprod. 2018;33(1):58\u201364. https:\/\/doi.org\/10.1093\/humrep\/dex334.","journal-title":"Hum Reprod"},{"key":"2140_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7827-10-32","volume":"10","author":"K Fiedler","year":"2012","unstructured":"Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32. https:\/\/doi.org\/10.1186\/1477-7827-10-32.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"2140_CR51","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379. https:\/\/doi.org\/10.1093\/humupd\/dmx017.","journal-title":"Hum Reprod Update"},{"key":"2140_CR52","doi-asserted-by":"publisher","first-page":"1191827","DOI":"10.3389\/fendo.2023.1191827","volume":"14","author":"R Zhou","year":"2023","unstructured":"Zhou R, Dong M, Huang L, Zhu X, Wei J, Zhang Q, et al. Association between serum LH levels on hCG trigger day and live birth rate after fresh embryo transfer with GnRH antagonist regimen in different populations. Front Endocrinol (Lausanne). 2023;14:1191827. https:\/\/doi.org\/10.3389\/fendo.2023.1191827.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2140_CR53","doi-asserted-by":"publisher","first-page":"1000047","DOI":"10.3389\/fendo.2022.1000047","volume":"13","author":"C Huang","year":"2022","unstructured":"Huang C, Shen X, Shi Q, Shan H, Yan Y, Liu J, et al. Adverse impact of elevated serum progesterone and luteinizing hormone levels on the hCG trigger day on clinical pregnancy outcomes of modified natural frozen-thawed embryo transfer cycles. Front Endocrinol (Lausanne). 2022;13:1000047. https:\/\/doi.org\/10.3389\/fendo.2022.1000047.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2140_CR54","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/humrep\/deab172","volume":"36","author":"R Zhou","year":"2021","unstructured":"Zhou R, Zhang X, Dong M, Huang L, Zhu X, Wang S, et al. Association between endogenous LH level prior to progesterone administration and live birth rate in artificial frozen-thawed blastocyst transfer cycles of ovulatory women. Hum Reprod. 2021;36(10):2687\u201396. https:\/\/doi.org\/10.1093\/humrep\/deab172.","journal-title":"Hum Reprod"},{"issue":"1","key":"2140_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12958-022-00888-4","volume":"20","author":"W Zhang","year":"2022","unstructured":"Zhang W, Liu Z, Liu M, Li J, Guan Y. Is it necessary to monitor the serum luteinizing hormone (LH) concentration on the human chorionic gonadotropin (HCG) day among young women during the follicular-phase long protocol? A retrospective cohort study. Reprod Biol Endocrinol. 2022;20(1):24. https:\/\/doi.org\/10.1186\/s12958-022-00888-4.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02140-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:59:44Z","timestamp":1784249984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02140-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02140-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Ethical Committee of Anhui Medical University (No. 20160270). The study was conducted in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. Given the retrospective nature of the study and the use of de-identified patient data, the requirement for informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}